 |
 |

Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their Clinical Review, Dr Sink and colleagues1 accurately capture the dilemma faced by clinicians caring for individuals with dementia: although neuropsychiatric symptoms are almost universal and adversely affect both patients and caregivers, evidence-based guidance toward effective pharmacological treatment is sparse. Inadequacy of present systems of symptom classification may account in part for the finding of limited usefulness for pharmacotherapy.
Agitation, delusions, and many other neuropsychiatric symptoms in dementia often present in ways that defy categorization by standard methods (eg, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM-IV]). Most treatment studies to date have defined these symptoms as isolated disturbances, such as aggression or anxiety, or as a score above a cutoff on instruments assessing multiple domains. However, neuropsychiatric symptoms frequently occur as specific clusters or syndromes2; 1 study using latent class analysis3 found that neuropsychiatric symptoms in Alzheimer disease clustered . . . [Full Text of this Article]
Martin Steinberg, MD
martins@jhmi.edu
Constantine Lyketsos, MD, MHS
Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore, Md
RELATED ARTICLES
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia
Pierre N. Tariot
JAMA. 2005;293(18):2212.
EXTRACT
| FULL TEXT
Pharmacological Treatment of Neuropsychiatric Symptoms of DementiaReply
Kaycee M. Sink and Kristine Yaffe
JAMA. 2005;293(18):2212.
EXTRACT
| FULL TEXT
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Kaycee M. Sink, Karen F. Holden, and Kristine Yaffe
JAMA. 2005;293(5):596-608.
ABSTRACT
| FULL TEXT
|